Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Plasma from recovered patients recently received a controversial FDA emergency use authorization as a potential treatment for COVID-19.
“The SalivaDirect test...is yet another testing innovation game changer that will reduce the demand for scarce testing resources.”
Oncologist wins Senate backing by a vote of 72 to 18.
The dietary supplement is derived from an Asian plant and has effects similar to opioids.
Acting Commissioner Ned Sharpless will return to lead the National Cancer Institute.
The FDA and the DEA issued joint warning letters to several websites telling them to stop or face severe legal consequences.
Alert comes after 63 reports of such outcomes, largely in people who should not have received Mavyret, Zepatier or Vosevi.
A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.
Researchers reached this conclusion after reviewing data on more than 30,000 people.
Between August 2018 and January 2019, the FDA doubled the number of liver cancer treatments.
A placebo-controlled study of obeticholic acid showed it improved liver fibrosis with no worsening of non-alcoholic steatohepatitis.
Stella Armstrong’s journey to a healthier life wasn’t easy.
The freezer section staples have been implicated in four major outbreaks over the past 20 years.
With the approval of Cyramza, there are now five targeted therapies for hepatocellular carcinoma.
Unused medication needs to be disposed of safely.
In a recent statement, the Food and Drug Administration underscored the need for better technologies to protect the nation’s blood supply.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.